Antiamnesic Activity of an Ayurvedic Formulation Chyawanprash in Mice
Table 2
Effect of Chy on day 4 ELT and day 5 time spent in target quadrant (TSTQ) of mice using MWM.
Group
Treatment
Dose
Day 1 ELT (s)
Day 4 ELT (s)
Day 5 TSTQ (s)
I
Control (normal)
Standard diet
69.7 ± 2.4
25.6 ± 1.8a
73.4 ± 3.6
II
Chy
1% w/w, in diet
68.6 ± 1.6
24.2 ± 2.4
70.6 ± 4.2
III
Chy
2% w/w, in diet
65.6 ± 0.6
26.7 ± 2.9
72.8 ± 2.4
IV
Piracetam
400 mg kg−1; i.p.
67.9 ± 3.9
13.4 ± 3.1b
89.9 ± 2.2e
V
Sco
1.4 mg kg−1; i.p.
66.3 ± 3.5
56.2 ± 3.6b
29.2 ± 4.9e
VI
Chy + Sco
1% w/w, in diet + 1.4 mg kg−1; i.p.
64.3 ± 1.2
34.8 ± 2.1c
52.1 ± 1.8f
VII
Chy + Sco
2% w/w, in diet + 1.4 mg kg−1; i.p.
62.1 ± 4.3
25.4 ± 1.3c
61.2 ± 4.6f
VIII
Piracetam + Sco
400 mg kg−1; i.p. + 1.4 mg kg−1; i.p.
62.3 ± 2.9
14.4 ± 2.7c
66.3 ± 2.8f
IX
Alp
0.5 mg kg−1; i.p.
63.4 ± 2.9
59.9 ± 4.3b
24.3 ± 1.2e
X
Chy + Alp
1% w/w, in diet + 0.5 mg kg−1; i.p.
63.7 ± 2.7
32.1 ± 1.6d
54.2 ± 3.2g
XI
Chy + Alp
2% w/w, in diet + 0.5 mg kg−1; i.p.
60.1 ± 2.5
22.1 ± 4.1d
64.6 ± 3.7g
XII
Piracetam + Alp
400 mg kg−1; i.p. + 0.5 mg kg−1; i.p.
66.3 ± 1.9
17.3 ± 2.3d
69.1 ± 3.6g
Piracetam (400 mg kg−1; i.p.) is used as a standard drug. Values are mean ± SEM.
aP < .05 as compared to day 1 ELT in control.
bP < .05 as compared to day 4 ELT in control.
cP < .05 as compared with day 4 ELT in Sco group.
dP < .05 as compared with day 4 ELT in Alp group.
eP < .05 as compared to day 5 TSTQ in control.
fP < .05 as compared with day 5 TSTQ in Sco group.
gP < .05 as compared with day 5 TSTQ in Alp group.